Efficacious, Orally Bioavailable Thrombin Inhibitors Based on 3-Aminopyridinone or 3-Aminopyrazinone Acetamide Peptidomimetic Templates
Philip E.J. Sanderson(United States Military Academy), Terry A. Lyle(United States Military Academy), Kellie J. Cutrona(United States Military Academy), Dona L. Dyer(United States Military Academy), Bruce D. Dorsey(United States Military Academy), Colleen M. McDonough(United States Military Academy), Adel M. Naylor-Olsen(United States Military Academy), I‐Wu Chen(United States Military Academy), Zhongguo Chen(United States Military Academy), Jacquelynn J. Cook(United States Military Academy), Carolyn M. Cooper(United States Military Academy), Stephen J. Gardell(United States Military Academy), Timothy R. Hare(United States Military Academy), Julie A. Krueger(United States Military Academy), Sidney D. Lewis(United States Military Academy), Jiunn H. Lin(United States Military Academy), Bobby J. Lucas(United States Military Academy), Elizabeth A. Lyle(United States Military Academy), Joseph J. Lynch(United States Military Academy), Maria T. Stranieri(United States Military Academy), Kari Vastag(United States Military Academy), Youwei Yan(United States Military Academy), Jules A. Shafer(United States Military Academy), Joseph P. Vacca(United States Military Academy)
Cited by 85Open Access
Abstract
We have addressed the key deficiency of noncovalent pyridinone acetamide thrombin inhibitor L-374,087 (1), namely, its modest half-lives in animals, by making a chemically stable 3-alkylaminopyrazinone bioisostere for its 3-sulfonylaminopyridinone core. Compound 3 (L-375,378), the closest aminopyrazinone analogue of 1, has comparable selectivity and slightly decreased efficacy but significantly improved pharmacokinetics in rats, dogs, and monkeys to 1. We have developed an efficient and versatile synthesis of 3, and this compound has been chosen for further preclinical and clinical development.
Related Papers
No related papers found
Powered by citation graph analysis